BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6204487)

  • 1. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies.
    Asbrink E; Hovmark A
    Acta Derm Venereol; 1984; 64(3):243-6. PubMed ID: 6204487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE in the serum and on mast cells in bullous pemphigoid.
    Nieboer C; van Leeuwen HJ
    Arch Dermatol; 1980 May; 116(5):555-6. PubMed ID: 6990870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgE levels in patients with bullous pemphigoid.
    Nieboer C
    Acta Derm Venereol; 1985; 65(3):273-4. PubMed ID: 2411092
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
    Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
    Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-basement membrane antibodies in sera from patients without bullous pemphigoid.
    Ullman S; Halberg P; Nielsen R
    Acta Derm Venereol; 1975; 55(4):305-8. PubMed ID: 52261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 7. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.
    Engineer L; Bhol K; Kumari S; Razzaque Ahmed A
    Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papules with basement membrane zone antibodies preceding bullous pemphigoid.
    Lorette G; Fetissoff F
    Arch Dermatol; 1982 Nov; 118(11):878-9. PubMed ID: 6753763
    [No Abstract]   [Full Text] [Related]  

  • 10. Subclass distribution of IgG autoantibodies in bullous pemphigoid.
    Bird P; Friedmann PS; Ling N; Bird AG; Thompson RA
    J Invest Dermatol; 1986 Jan; 86(1):21-5. PubMed ID: 3528304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum anti-basement membrane zone antibody and malignancy in bullous pemphigoid.
    Ahmed AR; Amerian ML
    Dermatologica; 1985; 171(2):82-5. PubMed ID: 3899759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
    Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
    Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cicatricial pemphigoid with circulating antibasement membrane antibodies. Report of three atypical cases.
    Person JR; Rogers RS; Jordon RE
    Dermatologica; 1977; 154(2):90-7. PubMed ID: 323083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid.
    Hadi SM; Barnetson RS; Gawkrodger DJ; Saxena U; Bird P; Merrett TG
    Dermatologica; 1988; 176(1):6-17. PubMed ID: 3276569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.
    Baba T; Sonozaki H; Seki K; Uchiyama M; Ikesawa Y; Toriisu M
    J Immunol; 1976 Jan; 116(1):112-6. PubMed ID: 1107422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic lupus erythematosus with bullous manifestations. Association with bullous pemphigoid and a rare presentation of systemic lupus erythematosus].
    Bittencourt AL; Brito E; Sadigursky M; Dias NF
    Acta Med Port; 1984; 5(4-5):119-25. PubMed ID: 6380218
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic bullous disease with coexistent circulating IgG and IgA anti-basement membrane zone antibodies.
    Miyagawa S; Kiriyama Y; Shirai T; Ohi H; Sakamoto K
    Arch Dermatol; 1981 Jun; 117(6):349-53. PubMed ID: 7018404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.